This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, everyone, and welcome to this Medscape InDiscussion podcast. Today we're talking about chronic thromboembolic pulmonary ...
HUNTINGDON VALLEY, Pa. (WPVI) -- Blood clots are always cause for concern. When clots develop in the arteries of the lungs, they can lead to a dangerous condition called CTEPH. Now, a Philadelphia ...
Hosted on MSN
Prognosis for chronic thromboembolic pulmonary hypertension has improved over recent decades, study finds
Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...
Please provide your email address to receive an email when new articles are posted on . Patients who received apixaban or rivaroxaban after cardiac surgery were no more likely to experience major ...
Philadelphia-based Temple University Hospital has achieved twin milestones in the treatment of chronic thromboembolic pulmonary hypertension. Care teams from the Advanced Pulmonary Hypertension, Right ...
26 April 2025, Boston—Chronic thromboembolic pulmonary hypertension (CTEPH) often goes undiagnosed for years, is frequently caught late, and primarily affects young, otherwise healthy individuals.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results